NeuroSense Therapeutics
NRSN
NRSN
11 hedge funds and large institutions have $181K invested in NeuroSense Therapeutics in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
77% less capital invested
Capital invested by funds: $776K → $181K (-$595K)
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$305K | |
| 2 | -$77.6K | |
| 3 | -$77K | |
| 4 |
Morgan Stanley
New York
|
-$48.4K |
| 5 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$24K |